UHS

Business Context and Reporting Period

Company: Universal Health Services, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended June 30, 2002
Business Overview: The Company operates acute care hospitals and behavioral health care facilities in the U.S., Puerto Rico, and France. Operations are segmented into Acute Care Services, Behavioral Health Services, and Other (including centralized services and French operations).

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net revenues increased 12% ($87 million) for the quarter and 15% ($215 million) for the six months compared to the prior year. Growth was driven by organic increases (7-8%) at existing facilities and acquisitions ($38 million for the quarter; $98 million for six months).
• Profitability: Operating income rose 17% for the quarter and 16% for the six months. Operating margins improved to 16.0% (quarter) and 16.2% (six months) from 15.4% and 16.0% respectively.
• Bad Debt Reduction: The provision for doubtful accounts decreased significantly as a percentage of net revenues (6.6% in Q2 2002 vs. 8.7% in Q2 2001), attributed to improved billing and collection procedures.
• Expense Pressures: Margins were partially offset by a significant increase in professional and general liability insurance expenses and rising labor costs (salaries, wages, and benefits).
• Accounting Changes: The Company adopted SFAS No. 142 effective January 1, 2002, ceasing the amortization of goodwill. This resulted in a decrease in depreciation and amortization expense compared to the prior year.

Guidance, Outlook, Risks, and Unusual Items

• Capital Expenditures: The Company spent $97 million in the first six months of 2002. It projects total capital expenditures for the full year 2002 to be between $200 million and $225 million, funding major projects including a new hospital in Las Vegas and renovations in Washington D.C. and Texas.
• Insurance Risk (PHICO): Following the liquidation of insurer PHICO, the Company recorded a $40 million pre-tax charge in Q4 2001. While factors have not substantially changed as of June 30, 2002, there is no assurance that ultimate liability will not exceed the reserve, which could materially affect future results.
• Insurance Costs: Due to unfavorable market trends, the Company expects total insurance expense to increase approximately $25 million in 2002 compared to 2001. Subsidiaries have assumed greater self-insured risk.
• Regulatory Environment: Reimbursement rates from Medicare and Medicaid remain subject to legislative changes (e.g., Balanced Budget Act of 1997). The Company anticipates continued pressure from managed care payors and admission constraints.
• Liquidity: As of June 30, 2002, the Company had $333 million of unused borrowing capacity under a $400 million revolving credit agreement. Total debt as a percentage of total capitalization was 43%.
• Accountant Change: The Company dismissed Arthur Andersen LLP and retained KPMG LLP as independent accountants effective June 18, 2002.

Investor Verification Checklist

• PHICO Liability: Verify the status of the $40 million reserve and potential exposure from the liquidation of PHICO, including the timeline for claim settlements.
• Insurance Expense Trajectory: Monitor the actual increase in professional and general liability insurance costs against the projected $25 million increase for 2002.
• Capital Project Execution: Track the completion and cost overruns of major capital projects, specifically the George Washington University Hospital and the Las Vegas facility.
• Reimbursement Rates: Assess the impact of Medicare/Medicaid rate updates and managed care contract renewals on future revenue per admission.
• Goodwill Impairment: Review the annual goodwill impairment testing results (scheduled for September 1st) given the cessation of amortization under SFAS No. 142.